Literature DB >> 22646509

Medication reconciliation for controlled substances--an "ideal" prescription-drug monitoring program.

Jeanmarie Perrone1, Lewis S Nelson.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22646509     DOI： 10.1056/NEJMp1204493

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  24 in total

Review 1.  Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related Pain.

Authors:  Esad Ulker; Egidio Del Fabbro
Journal:  Oncologist       Date:  2019-12-24

2.  The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.

Authors:  Chris Ringwalt; Mariana Garrettson; Apostolos Alexandridis
Journal:  J Prim Prev       Date:  2015-04

Review 3.  Strategies to Identify and Reduce Opioid Misuse Among Patients with Gastrointestinal Disorders: A Systematic Scoping Review.

Authors:  Salva N Balbale; Itishree Trivedi; Linda C O'Dwyer; Megan C McHugh; Charlesnika T Evans; Neil Jordan; Laurie A Keefer
Journal:  Dig Dis Sci       Date:  2017-08-05       Impact factor: 3.199

4.  Impact of a prescription drug monitoring program use mandate on potentially problematic patterns of opioid analgesic prescriptions in New York City.

Authors:  Marcus A Bachhuber; Ellenie Tuazon; Michelle L Nolan; Hillary V Kunins; Denise Paone
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-03-28       Impact factor: 2.890

Review 5.  Windmills and pill mills: can PDMPs tilt the prescription drug epidemic?

Authors:  Hallam Gugelmann; Jeanmarie Perrone; Lewis Nelson
Journal:  J Med Toxicol       Date:  2012-12

6.  Early experience with electronic prescribing of controlled substances in a community setting.

Authors:  Cindy Parks Thomas; Meelee Kim; Stephen J Kelleher; Ruslan V Nikitin; Peter W Kreiner; Ann McDonald; Grant M Carrow
Journal:  J Am Med Inform Assoc       Date:  2013-04-05       Impact factor: 4.497

7.  Prescription drug monitoring and dispensing of prescription opioids.

Authors:  Joanne E Brady; Hannah Wunsch; Charles DiMaggio; Barbara H Lang; James Giglio; Guohua Li
Journal:  Public Health Rep       Date:  2014 Mar-Apr       Impact factor: 2.792

Review 8.  Assuring safety of inherently unsafe medications: the FDA risk evaluation and mitigation strategies.

Authors:  Lewis S Nelson; Meredith Loh; Jeanmarie Perrone
Journal:  J Med Toxicol       Date:  2014-06

9.  Mandatory use of prescription drug monitoring programs.

Authors:  Rebecca L Haffajee; Anupam B Jena; Scott G Weiner
Journal:  JAMA       Date:  2015-03-03       Impact factor: 56.272

10.  How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?

Authors:  Robert J Smith; Austin S Kilaru; Jeanmarie Perrone; Breah Paciotti; Frances K Barg; Sarah M Gadsden; Zachary F Meisel
Journal:  Pain Med       Date:  2015-02-17       Impact factor: 3.750
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.